The Library
Effect of mammographic service screening on stage at presentation of breast cancers in Sweden
Tools
Tools
Tools
(2007) Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer, 109 (11). pp. 2205-2212. doi:10.1002/cncr.22671 ISSN 0008-543X.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: https://doi.org/10.1002/cncr.22671
Abstract
BACKGROUND. Previous results have shown a reduction in mortality with service screening in Sweden on the order of 40%. If the rate of tumors at a later stage were similarly reduced, this would give further support to the mortality findings. METHODS. The rates of lymph node-positive cancers, of tumors >2 cm in pathological size, and of tumors of TNM stage II or worse before and after the introduction of screening were compared in 13 areas in Sweden, adjusted for changes in overall incidence during the period of study and stratified by age (40-49 and 50-69 years). RESULTS. Data were obtained on a total of 23,092 cancers and 10,177,113 person-years of observation. In women exposed to screening in the screening epoch, there was a significant 45% reduction in tumors of size >2 cm compared with the prescreening (relative risk [RR] = 0.55, 95% confidence interval [CI]: 0.46-0.66) in the 40-49 age group, and a 33% reduction in the 50-69 group (RR = 0.67, 95% CI: 0.62-0.72). For lymph node-positive and stage II+ disease, there were smaller but still significant reductions. No reduction in incidence in later-stage disease was observed in the unexposed women in the screening epoch. CONCLUSIONS. Screening has significantly and substantially reduced the rates of larger tumors and lymph node-positive breast cancer in Sweden, and the magnitude of the reduction is consistent with the reduction in breast cancer mortality. © 2007 American Cancer Society.
| Item Type: | Journal Article | ||||||
|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > R Medicine (General) | ||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||
| Journal or Publication Title: | Cancer | ||||||
| Publisher: | John Wiley & Sons, Inc. | ||||||
| ISSN: | 0008-543X | ||||||
| Official Date: | 1 June 2007 | ||||||
| Dates: |
|
||||||
| Volume: | 109 | ||||||
| Number: | 11 | ||||||
| Page Range: | pp. 2205-2212 | ||||||
| DOI: | 10.1002/cncr.22671 | ||||||
| Status: | Peer Reviewed | ||||||
| Publication Status: | Published | ||||||
| Access rights to Published version: | Restricted or Subscription Access | ||||||
| Date of first compliant deposit: | 23 July 2018 | ||||||
| Date of first compliant Open Access: | 10 August 2018 |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
